Epidemiology and management of candidaemia - a retrospective, multicentre study in five hospitals in the UK

Mycoses

Volumn 54, Issue 6, 2011, Pages

  Chalmers, C ^a   Gaur, S ^b   Chew, J ^a   Wright, T ^a   Kumar, A ^c   Mathur, S ^d   Wan, W Y ^e   Gould, I M ^c   Leanord, A ^d   Bal, A M ^a  

^a CROSSHOUSE HOSPITAL   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^d SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^e PRINCE CHARLES HOSPITAL   (United Kingdom)

Author keywords

Antifungal agents; Candidaemia; Epidemiology

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; FLUCONAZOLE; NYSTATIN; VORICONAZOLE;

ADULT; ANTIFUNGAL SUSCEPTIBILITY; ANTIMICROBIAL THERAPY; ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CENTRAL VENOUS CATHETER; CHILD; CLAVISPORA LUSITANIAE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; NONHUMAN; PICHIA GUILLIERMONDII; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; CATHETER-RELATED INFECTIONS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; FLUCONAZOLE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCOTLAND; SURVIVAL ANALYSIS; WALES; YOUNG ADULT;

CANDIDA; CANDIDA ALBICANS;

EID: 80955180957     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2011.02027.x     Document Type: Article

References (18)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-17.
2. Odds FC, Hanson MF, Davidson AD et al. One year prospective survey of Candida bloodstream infections in Scotland. J Med Microbiol 2007; 56: 1066-75.
3. Kibbler CC, Seaton S, Barnes RA et al. Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 2003; 54: 18-24.
4. Aliyu SH, Enoch DA, Abubakar II, Ali R, Carmichael AJ, Farrington M. Candidaemia in a large teaching hospital: a clinical audit. Q J Med 2006; 99: 655-63.
5. Denning DW, Kibbler CC, Barnes RA. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 2003; 3: 230-40.
6. The Scottish Intensive Care Society Audit Group. Audit of Critical Care in Scotland 2009. Reporting on 2008 [WWW document], 2009. URL [accessed on 6 March 2010].
7. Pfaller MA, Diekema DJ, Sheehan DJ. Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev 2006; 19: 435-47.
8. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-35.
9. Garey KW, Turpin RS, Bearden DT, Pai MP, Suda KJ. Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study. Int J Antimicrob Agents 2007; 29: 557-62.
10. Parkins MD, Sabuda DM, Elsayed S, Laupland KB. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 2007; 60: 613-8.
11. Eggimann P, Francioli P, Bille J et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999; 27: 1066-72.
12. Schuster MG, Edwards JE Jr, Sobel JD et al. Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 2008; 149: 83-90.
13. Schelenz S. Management of candidiasis in the intensive care unit. J Antimicrob Chemother 2008; 61(Suppl. 1): i31-i34.
14. Schelenz S, Gransden WR. Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period. Mycoses 2003; 46: 390-6.
15. Donahue SP, Greven CM, Zuravleff JJ et al. Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology 1994; 101: 1302-9.
16. Schelenz S, Barnes RA, Kibbler CC, Jones BL, Denning DW. Standards of care for patients with invasive fungal infections within the United Kingdom: a national audit. J Infect 2009; 58: 145-53.
17. Nucci M, Anaissie E. Should vascular catheters be removed from all patients with candidaemia? An evidence based review. Clin Infect Dis 2002; 34: 591-9.
18. Nucci M, Anaissie E, Betts RF et al. Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis 2010; 51: 295-303.